Empire State Realty Trust Reports Tomorrow With Tourism Still Unresolved

Empire State Realty Trust Inc (ESRT) reports second-quarter 2026 earnings after the close on July 29, with the iconic office REIT facing questions about occupancy trends and leasing momentum in a challenging Manhattan market. With no analyst estimates available for the quarter, investors will focus on operational metrics and management commentary to gauge whether the company can sustain the earnings trajectory established over the past year.

Part 1: Earnings Preview

Empire State Realty Trust is a real estate investment trust that owns and operates office and retail properties in Manhattan and the greater New York metropolitan area, with its flagship Empire State Building serving as the centerpiece of its portfolio. The company reports Q2 2026 results after market close on July 29, 2026, with no consensus EPS or revenue estimates available from analysts. ESRT most recently reported Q1 2026 EPS of $0.20, down from $0.22 in the year-ago quarter.

Comparing to the same quarter last year (Q2 2025), when ESRT reported EPS of $0.22, investors will be watching whether the company can match or exceed that performance amid ongoing challenges in the New York office market.

Three key themes define this earnings story:

Manhattan Office Market Recovery: The pace of return-to-office mandates and tenant demand for Class A space in Midtown will be critical, particularly given broader economic uncertainty reflected in President Trump's record-low approval ratings and concerns about trade policy impacting business confidence.

Leasing Velocity and Occupancy: New lease signings and renewal activity will signal whether ESRT can maintain occupancy levels and pricing power in its portfolio, especially at the Empire State Building and other trophy assets.

Capital Allocation and Balance Sheet: With the stock trading well below its 200-day moving average, investors will scrutinize management's approach to capital deployment, dividend sustainability, and any portfolio optimization moves.

Analyst commentary ahead of the release has been limited given the lack of published estimates, though the current consensus of 2 Strong Buys, 3 Holds, and 1 Strong Sell suggests a cautiously optimistic view with a mean price target of $6.35 implying 12% upside from current levels.

Part 2: Historical Earnings Performance

ESRT has delivered consistent earnings over the past four quarters, though without analyst estimates available for comparison, the pattern shows modest quarterly variation rather than clear beats or misses. The company reported $0.22 in Q2 2025, $0.23 in Q3 2025, $0.23 in Q4 2025, and $0.20 in Q1 2026.

The trend reveals relative stability in the $0.20-$0.23 range, with the most recent quarter's $0.20 representing the low end of that band. The sequential decline from $0.23 in Q4 2025 to $0.20 in Q1 2026 suggests potential seasonal factors or specific portfolio challenges that investors will want management to address on the upcoming call.

With Q2 2025 having produced $0.22 in EPS, matching or exceeding that figure would demonstrate year-over-year stability, while falling short could raise concerns about the company's ability to maintain its earnings power in the current operating environment.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

ESRT reports after market close, meaning Day 0 captures anticipatory trading before results are released, while Day +1 reflects the market's first full session to digest the actual numbers.

Historical price action around ESRT earnings shows moderate volatility, with an average absolute Day 0 move of 2.24% and Day +1 move of 2.91%. The Day 0 trading range averages 3.30%, expanding to 6.01% on Day +1 as the market fully processes results and guidance.

The pattern has been somewhat directionally mixed, with recent quarters showing both sharp declines (July 2025's 7.05% Day +1 drop, October 2025's 6.04% Day +1 decline) and more muted reactions. The most recent April 2026 report saw a relatively contained 1.92% Day 0 decline followed by a modest 0.89% Day +1 dip, suggesting investors may be growing more comfortable with the company's performance trajectory. Based on historical patterns, investors should anticipate a move in the 2-3% range on earnings day, with potential for wider swings depending on guidance and operational commentary.

Part 2.2: Options Market Expected Move

The options market is pricing in a 0.00% expected move for the August 21 expiration, which appears to be a data anomaly given the stock's historical earnings volatility averaging 2.24% on Day 0 and 2.91% on Day +1. With average volatility of 71.47% and minimal open interest of just 16 contracts, the options market for ESRT appears illiquid and may not be providing a reliable signal for this earnings event.

Part 3: What Analysts Are Saying

Analysts maintain a cautiously optimistic stance on ESRT with an average recommendation of 3.33 (between Hold and Buy), unchanged over the past month. The consensus includes 2 Strong Buys, 3 Holds, and 1 Strong Sell, reflecting divided opinions on the stock's prospects.

The mean price target of $6.35 implies approximately 12% upside from the current price of $5.66, with estimates ranging from a low of $5.75 to a high of $7.00. The sentiment trend is classified as unchanged, indicating analysts have not materially revised their views in recent weeks despite the stock's recent technical improvement.

The rating distribution suggests analysts see value in ESRT's Manhattan office portfolio and iconic assets, but remain cautious about near-term catalysts given the uncertain office market recovery and broader economic headwinds. The presence of one Strong Sell rating alongside two Strong Buys highlights the polarized views on whether the company's current valuation adequately reflects both its trophy asset quality and the structural challenges facing urban office REITs.

Part 4: Technical Picture

ESRT enters earnings with improving technical momentum after a period of weakness. The Barchart Technical Opinion has shifted from 100% Sell a month ago to 8% Sell last week, and now stands at 8% Buy, reflecting a notable reversal in short-term sentiment.

Timeframe Analysis:

• Short-term (50% Buy): Moderate buy signal indicates emerging near-term momentum as the stock recovers from recent lows
• Medium-term (Hold): Neutral reading suggests the intermediate trend remains in consolidation mode
• Long-term (50% Sell): Moderate sell signal reflects persistent weakness in the longer-term trend, with the stock still well below its 200-day average

Trend Characteristics: The Weak strength combined with Average direction suggests ESRT is in an early-stage recovery attempt that has not yet established conviction, creating an uncertain technical backdrop heading into earnings.

The stock is currently trading at $5.66, positioned above its 5-day ($5.57), 10-day ($5.61), 20-day ($5.56), 50-day ($5.49), and 100-day ($5.42) moving averages, but remains below the critical 200-day moving average of $6.10. This configuration shows short-term strength but highlights the significant overhead resistance that must be cleared to confirm a sustainable uptrend.

The 200-day moving average at $6.10 represents a key technical hurdle approximately 8% above current levels, aligning closely with the analyst consensus price target of $6.35. A strong earnings report that drives the stock through this level could trigger momentum-based buying, while disappointment could send ESRT back toward support in the $5.40-$5.50 range where the 50-day and 100-day averages reside. The technical setup is cautiously constructive but lacks the conviction of a strong trending environment, making the earnings release a potentially decisive catalyst for near-term direction.